Ekso Bionics Holdings Inc
EKSO
Get informed when a big investor buys or sells
+ FollowMarket Cap$28.63M
Close$
$4.71
60.1% downside
Current Fair Value
60.1% downsideOvervalued by 60.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $28.63 Million |
|---|---|
| Enterprise Value | $30.53 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-4.91 |
| Beta | 0.78 |
| Outstanding Shares | 3,563,000 |
Return
| Return on Equity | -273.33% |
|---|---|
| Return on Assets | -79.77% |
| Return on Invested Capital | -154.39% |
Valuation & Multiples
| P/E Ratio | -2.68 |
|---|---|
| PEG | -1.94 |
| Price to Sales | 3.93 |
| Price to Book Ratio | 11.8 |
| Enterprise Value to Revenue | 2.64 |
| Enterprise Value to EBIT | -1.87 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.19 |
| Debt to Equity | 1.03 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 4, 2026
EPS Estimate
$-0.03
Average shareholder expectationRevenue Estimate
$4.29 M
Average shareholder expectationNext Earnings Call
Expected Date
July 27, 2026
EPS Estimate
$-0.06
Average shareholder expectationRevenue Estimate
$2.51 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 37.56%▲ 27.74% |
|---|---|
| Total Invested | $17.22M▲ 675.94% |
| Investors Holding | 31▲ 5.00% |
ESG Score
No data
About Ekso Bionics Holdings Inc
CEO: Nathan Harding